Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/143326
Title: Anti-tumor effects of anti-Semaphorin 4D antibody unravel a novel pro-invasive mechanism of vascular targeting agents
Author: Zuazo Gaztelu, Iratxe
Pàez Ribes, Marta
Carrasco, Patricia
Martín Fernández, Laura
Soler, Adriana
Martínez Lozano, Mar
Pons, Roser
Llena, Judith
Palomero, Luis
Graupera i Garcia-Milà, Mariona
Casanovas Casanovas, Oriol
Keywords: Angiogènesi
Tumors
Neovascularization
Issue Date: 25-Jun-2019
Publisher: AACR Publications
Abstract: One of the main consequences of inhibition of neovessel growth and vessel pruning produced by angiogenesis inhibitors is increased intratumor hypoxia. Growing evidence indicates that tumor cells escape from this hypoxic environment to better nourished locations, presenting hypoxia as a positive stimulus for invasion. In particular, anti-VEGF/R therapies produce hypoxia-induced invasion and metastasis in a spontaneous mouse model of pancreatic neuroendocrine cancer (PanNET), RIP1-Tag2. Here, a novel vascular-targeting agent targeting semaphorin 4D (Sema4D) demonstrated impaired tumor growth and extended survival in the RIP1-Tag2 model. Surprisingly, although there was no induction of intratumor hypoxia by anti-Sema4D therapy, the increase in local invasion and distant metastases was comparable with the one produced by VEGFR inhibition. Mechanistically, the antitumor effect was due to an alteration in vascular function by modification of pericyte coverage involving platelet-derived growth factor B. On the other hand, the aggressive phenotype involved a macrophage-derived Sema4D signaling engagement, which induced their recruitment to the tumor invasive fronts and secretion of stromal cell–derived factor 1 (SDF1) that triggered tumor cell invasive behavior via CXCR4. A comprehensive clinical validation of the targets in different stages of PanNETs demonstrated the implication of both Sema4D and CXCR4 in tumor progression. Taken together, we demonstrate beneficial antitumor and prosurvival effects of anti-Sema4D antibody but also unravel a novel mechanism of tumor aggressivity. This mechanism implicates recruitment of Sema4D-positive macrophages to invasive fronts and their secretion of proinvasive molecules that ultimately induce local tumor invasion and distant metastasis in PanNETs.
URI: http://hdl.handle.net/2445/143326
Related resource: http://dx.doi.org/10.1158/0008-5472.CAN-18-3436
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Zuazo-Gaztelu2019Accepted.pdf2.78 MBAdobe PDFView/Open    Request a copy


Embargat   Document embargat fins el 25-6-2020


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.